Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Craneware ( (GB:CRW) ) is now available.
Craneware plc announced a positive trading update for the first half of the fiscal year 2025, with revenues surpassing $100 million and adjusted EBITDA reaching approximately $30.3 million, driven by the success of its Trisus platform and strategic partnerships. The company also appointed Susan Nelson as a Non-Executive Director, bringing extensive experience in healthcare finance, and anticipates a stable demand environment in the US healthcare market, supported by strong cash reserves and reduced debt.
More about Craneware
Craneware plc is a market leader in value cycle software solutions for the US healthcare market, collaborating with healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, and pharmacy management. Its flagship SaaS platform, Trisus, is designed to help healthcare organizations achieve operational and financial excellence.
YTD Price Performance: -2.61%
Average Trading Volume: 86,102
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £719.6M
Learn more about CRW stock on TipRanks’ Stock Analysis page.
